Format

Send to

Choose Destination
Oncogene. 2009 Oct 22;28(42):3681-8. doi: 10.1038/onc.2009.227. Epub 2009 Aug 3.

Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.

Author information

1
Prostate Cancer Discovery and Development Program, Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Abstract

There is a plethora of attractive drug targets in cancer, but their therapeutic exploitation proved more difficult than expected, and only rarely truly successful. One possibility not often considered in drug discovery is that cancer signaling pathways are not randomly arranged in cells, but orchestrated in specialized subcellular compartments. The identification of heat shock protein-90 (Hsp90) chaperones in mitochondria of tumors, but not most normal tissues, provides an example of a compartmentalized network of cell survival, opening fresh prospects for novel, subcellularly targeted cancer drug discovery.

PMID:
19648961
PMCID:
PMC2766018
DOI:
10.1038/onc.2009.227
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center